Prevention and management of drug resistance for antihepatitis B treatment-Reference-Cited by-同舟云学术

Prevention and management of drug resistance for antihepatitis B treatment

Published:2009-04 Issue:4 Volume:9 Page:256-264
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Yuen Man-Fung,Fung James,Wong Danny Ka-Ho,Lai Ching-Lung

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference85 articles.

1. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission;Okamoto;Jpn J Exp Med,1987

2. Mutation rate of the hepadnavirus genome;Girones;Virology,1989

3. Viral dynamics in hepatitis B virus infection;Nowak;Proc Natl Acad Sci USA,1996

4. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment;Kirishima;J Hepatol,2002

5. Hepatitis B virus polymerase variants associated with entecavir drug resistance in treatment-naive patients;Jardi;J Viral Hepat,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal resistance in superficial mycoses;Journal of Dermatological Treatment;2021-06-30

2. Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19;Pharmacological Reports;2020-07-22

3. Fungal metabolites—A potential source of antiviral compounds;New and Future Developments in Microbial Biotechnology and Bioengineering;2020

4. Clinical Manifestations and Laboratory Tests of AECHB and Severe Hepatitis (Liver Failure);Acute Exacerbation of Chronic Hepatitis B;2019

5. Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model;The Brazilian Journal of Infectious Diseases;2018-11